Beyond the Beyond: A Case of an Extraordinary Response to Multiple Lines of Therapy in a de novo Metastatic HER2-Negative Gastric Cancer Patient

被引：4

作者：

Baldessari, Cinzia ^{[1
]}

Gelsomino, Fabio ^{[1
]}

Spallanzani, Andrea ^{[1
]}

Pugliese, Giuseppe ^{[1
]}

Bonetti, Luca Reggiani ^{[2
]}

Bettelli, Stefania ^{[2
]}

Cascinu, Stefano ^{[1
]}

机构：

[1] Univ Modena & Reggio Emilia, Dept Haematol & Oncol, Policlin Modena, Via Pozzo 71, IT-41124 Modena, Italy

[2] Univ Modena & Reggio Emilia, Policlin Modena, Sect Pathol, Dept Diagnost Med & Publ Hlth, Modena, Italy

来源：

GASTROINTESTINAL TUMORS | 2018年 / 5卷 / 1-2期

关键词：

Gastric cancer; Chemotherapy; Multiple lines;

D O I：

10.1159/000488983

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Background: Gastric cancer is the fourth cause of cancer-related death in Europe and the prognosis of these patients remains dismal. It has been demonstrated that chemotherapy improved survival compared with best supportive care and recently, subsequent lines of therapy, also with new drugs, obtained positive results. Summary: We present the case of a patient diagnosed with a de novo metastatic gastric cancer who experienced an extraordinary long response to multiple lines of chemotherapy (FOLFOX6, paclitaxel plus ramucirumab, FOLFIRI, rechallenge with FOLFOX6). Key Message: Gastric cancer therapy should be considered as the result of a strategy based on the patient's condition, and tolerance and response to various therapies. The emerging evidence of the role of subsequent lines of therapy, along with the recognition of the pivotal role of nutritional support and the availability of new drugs, should help clinicians in the management of patients with gastric cancer. Practical Implications: We propose a practical therapeutic algorithm in order to help clinicians who deal with patients with gastric cancer. (c) 2018 S. Karger AG, Basel

引用

页码：14 / 20

页数：7

共 20 条

[1]

Bang YJ, 2010, LANCET, V376, P1302

[2] Comprehensive molecular characterization of gastric adenocarcinoma [J].

Bass, Adam J. ;

Thorsson, Vesteinn ;

Shmulevich, Ilya ;

Reynolds, Sheila M. ;

Miller, Michael ;

Bernard, Brady ;

Hinoue, Toshinori ;

Laird, Peter W. ;

Curtis, Christina ;

Shen, Hui ;

Weisenberger, Daniel J. ;

Schultz, Nikolaus ;

Shen, Ronglai ;

Weinhold, Nils ;

Keiser, David P. ;

Bowlby, Reanne ;

Sipahimalani, Payal ;

Cherniack, Andrew D. ;

Getz, Gad ;

Liu, Yingchun ;

Noble, Michael S. ;

Pedamallu, Chandra ;

Sougnez, Carrie ;

Taylor-Weiner, Amaro ;

Akbani, Rehan ;

Lee, Ju-Seog ;

Liu, Wenbin ;

Mills, Gordon B. ;

Yang, Da ;

Zhang, Wei ;

Pantazi, Angeliki ;

Parfenov, Michael ;

Gulley, Margaret ;

Piazuelo, M. Blanca ;

Schneider, Barbara G. ;

Kim, Jihun ;

Boussioutas, Alex ;

Sheth, Margi ;

Demchok, John A. ;

Rabkin, Charles S. ;

Willis, Joseph E. ;

Ng, Sam ;

Garman, Katherine ;

Beer, David G. ;

Pennathur, Arjun ;

Raphael, Benjamin J. ;

Wu, Hsin-Ta ;

Odze, Robert ;

Kim, Hark K. ;

Bowen, Jay .

NATURE, 2014, 513 (7517) :202-209

[3] Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes [J].

Cristescu, Razvan ;

Lee, Jeeyun ;

Nebozhyn, Michael ;

Kim, Kyoung-Mee ;

Ting, Jason C. ;

Wong, Swee Seong ;

Liu, Jiangang ;

Yue, Yong Gang ;

Wang, Jian ;

Yu, Kun ;

Ye, Xiang S. ;

Do, In-Gu ;

Liu, Shawn ;

Gong, Lara ;

Fu, Jake ;

Jin, Jason Gang ;

Choi, Min Gew ;

Sohn, Tae Sung ;

Lee, Joon Ho ;

Bae, Jae Moon ;

Kim, Seung Tae ;

Park, Se Hoon ;

Sohn, Insuk ;

Jung, Sin-Ho ;

Tan, Patrick ;

Chen, Ronghua ;

Hardwick, James ;

Kang, Won Ki ;

Ayers, Mark ;

Dai Hongyue ;

Reinhard, Christoph ;

Loboda, Andrey ;

Kim, Sung ;

Aggarwal, Amit .

NATURE MEDICINE, 2015, 21 (05) :449-U217

[4] Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic Chemotherapy (vol 22, pg 1463, 2017) [J].

Fanotto, Valentina ;

Uccello, Mario ;

Pecora, Irene ;

Rimassa, Lorenza ;

Leone, Francesco ;

Rosati, Gerardo ;

Santini, Daniele ;

Giampieri, Riccardo ;

Di Donato, Samantha ;

Tomasello, Gianluca ;

Silvestris, Nicola ;

Pietrantonio, Filippo ;

Battaglin, Francesca ;

Avallone, Antonio ;

Scartozzi, Mario ;

Lutrino, Eufemia Stefania ;

Melisi, Davide ;

Antonuzzo, Lorenzo ;

Pellegrino, Antonio ;

Ferrari, Laura ;

Bordonaro, Roberto ;

Vivaldi, Caterina ;

Gerratana, Lorenzo ;

Bozzarelli, Silvia ;

Filippi, Roberto ;

Bilancia, Domenico ;

Russano, Marco ;

Aprile, Giuseppe .

ONCOLOGIST, 2018, 23 (02) :272-272

[5] Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012 [J].

Ferlay, J. ;

Steliarova-Foucher, E. ;

Lortet-Tieulent, J. ;

Rosso, S. ;

Coebergh, J. W. W. ;

Comber, H. ;

Forman, D. ;

Bray, F. .

EUROPEAN JOURNAL OF CANCER, 2013, 49 (06) :1374-1403

[6] Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial [J].

Ford, Hugo E. R. ;

Marshall, Andrea ;

Bridgewater, John A. ;

Janowitz, Tobias ;

Coxon, Fareeda Y. ;

Wadsley, Jonathan ;

Mansoor, Wasat ;

Fyfe, David ;

Madhusudan, Srinivasan ;

Middleton, Gary W. ;

Swinson, Daniel ;

Falk, Stephen ;

Chau, Ian ;

Cunningham, David ;

Kareclas, Paula ;

Cook, Natalie ;

Blazeby, Jane M. ;

Dunn, Janet A. .

LANCET ONCOLOGY, 2014, 15 (01) :78-86

[7] Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial [J].

Fuchs, Charles S. ;

Tomasek, Jiri ;

Yong, Cho Jae ;

Dumitru, Filip ;

Passalacqua, Rodolfo ;

Goswami, Chanchal ;

Safran, Howard ;

dos Santos, Lucas Vieira ;

Aprile, Giuseppe ;

Ferry, David R. ;

Melichar, Bohuslav ;

Tehfe, Mustapha ;

Topuzov, Eldar ;

Zalcberg, John Raymond ;

Chau, Ian ;

Campbell, William ;

Sivanandan, Choondal ;

Pikiel, Joanna ;

Koshiji, Minori ;

Hsu, Yanzhi ;

Liepa, Astra M. ;

Gao, Ling ;

Schwartz, Jonathan D. ;

Tabernero, Josep .

LANCET, 2014, 383 (9911) :31-39

[8] The continuum of care: A paradigm for the management of metastatic colorectal cancer [J].

Goldberg, Richard M. ;

Rothenberg, Mace L. ;

Van Cutsem, Eric ;

Benson, Al B., III ;

Blanke, Charles D. ;

Diasio, Robert B. ;

Grothey, Axel ;

Lenz, Heinz-Josef ;

Meropol, Neal J. ;

Ramanathan, Ramesh K. ;

Becerra, Carlos H. Roberto ;

Wickham, Rita ;

Armstrong, Delma ;

Viele, Carol .

ONCOLOGIST, 2007, 12 (01) :38-50

[9] Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment [J].

Grothey, A ;

Sargent, D ;

Goldberg, RM ;

Schmoll, HJ .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (07) :1209-1214

[10] Salvage Chemotherapy for Pretreated Gastric Cancer: A Randomized Phase III Trial Comparing Chemotherapy Plus Best Supportive Care With Best Supportive Care Alone [J].

Kang, Jung Hun ;

Lee, Soon Il ;

Lim, Do Hyoung ;

Park, Keon-Woo ;

Oh, Sung Yong ;

Kwon, Hyuk-Chan ;

Hwang, In Gyu ;

Lee, Sang-Cheol ;

Nam, Eunmi ;

Shin, Dong Bok ;

Lee, Jeeyun ;

Park, Joon Oh ;

Park, Young Suk ;

Lim, Ho Yeong ;

Kang, Won Ki ;

Park, Se Hoon .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (13) :1513-1518

← 1 2 →